| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2594 | |||||||||||||||||||||||
| Submitter : | Mrs. Mary Belton | Date & Time: | 12/05/2006 11:12:43 | |||||||||||||||||||||
| Organization : | Mrs. Mary Belton | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| In reference to Docket Number 2006D-0383: Please abandon the use of aborted human fetal cells (cell lines) for the production of vaccines! Instead, please use only morally/ethically acceptable lines produced from animal cell substrates and other biological starting materials. Thank-you. | ||||||||||||||||||||||||